Certara, Inc.
CERT
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guā¦ read more
Healthcare
Health Information Services
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$8.10
Price+4.11%
$0.32
1Y
Price
Market Cap
$1.260b
Small
Price/Earnings 3y Avg5y Avg
20.8x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+22.3%
EBITDA Margin+1.5%
Net Profit Margin+30.7%
Free Cash Flow Margin+22.3%
EBITDA Margin+1.5%
Net Profit Margin+30.7%
Free Cash Flow MarginRevenue
$419.749m
+7.9%
1y CAGR+7.4%
3y CAGR+9.9%
5y CAGREarnings
-$15.101m
+190.3%
1y CAGR-69.1%
3y CAGR+0.9%
5y CAGREPS
-$0.10
+187.5%
1y CAGR-74.7%
3y CAGR-6.1%
5y CAGRBook Value
$1.017b
$1.500b
Assets$483.324m
Liabilities$300.256m
DebtDebt to Assets
20.0%
2.8x
Debt to EBITDAFree Cash Flow
$82.850m
+33.3%
1y CAGR+6.5%
3y CAGR+24.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company